| # | Drug | Count |
|---|---|---|
| 0 | ASPIRIN | 58 |
| 1 | ASPIRIN 325 MG | 57 |
| 2 | ASPIRIN 81 MG | 57 |
| 3 | PREDNISONE | 53 |
| 4 | RUXOLITINIB | 46 |
| 5 | LENALIDOMIDE | 45 |
| 6 | METHOTREXATE SODIUM | 39 |
| 7 | ACETAMINOPHEN | 38 |
| 8 | METHOTREXATE | 35 |
| 9 | OMEPRAZOLE MAGNESIUM | 35 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | 20% BENZOCAINE | 1 | 0.1667 |
| 1 | PEGZILARGINASE-NBLN | 2 | 0.0645 |
| 2 | THIORIDAZINE HYDROCHLORIDE | 1 | 0.0179 |
| 3 | METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, METHYLENE BLUE, AND HYOSCYAMINE SULFATE | 1 | 0.0090 |
| 4 | CEFOTETAN | 1 | 0.0075 |
| 5 | ESMOLOL HYDROCHLORIDE | 1 | 0.0037 |
| 6 | DIFLUPREDNATE OPHTHALMIC | 3 | 0.0034 |
| 7 | VADADUSTAT | 1 | 0.0033 |
| 8 | INSULIN DEGLUDEC AND LIRAGLUTIDE | 5 | 0.0030 |
| 9 | METYRAPONE | 3 | 0.0030 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 110 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 105 |
| 2 | Kinase Inhibitor [EPC] | 102 |
| 3 | Platelet Aggregation Inhibitor [EPC] | 58 |
| 4 | Janus Kinase Inhibitor [EPC] | 55 |
| 5 | Thalidomide Analog [EPC] | 50 |
| 6 | Tumor Necrosis Factor Blocker [EPC] | 50 |
| 7 | Vitamin C [EPC] | 50 |
| 8 | Benzodiazepine [EPC] | 44 |
| 9 | Proton Pump Inhibitor [EPC] | 44 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Adrenal Steroid Synthesis Inhibitor [EPC] | 3 | 0.0030 |
| 1 | Hematopoietic Stem Cell Mobilizer [EPC] | 3 | 0.0020 |
| 2 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 3 | 0.0013 |
| 3 | Provitamin D2 Compound [EPC] | 32 | 0.0011 |
| 4 | Thrombopoietin Receptor Agonist [EPC] | 12 | 0.0008 |
| 5 | Human Immunoglobulin G [EPC] | 15 | 0.0007 |
| 6 | CD38-directed Cytolytic Antibody [EPC] | 4 | 0.0007 |
| 7 | Sulfone [EPC] | 7 | 0.0006 |
| 8 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 14 | 0.0006 |
| 9 | CD52-directed Cytolytic Antibody [EPC] | 10 | 0.0005 |